People: Takeda Pharmaceutical Co Ltd (TKPYY.PK)

TKPYY.PK on OTC Markets Group

23.43USD
23 May 2013
Price Change (% chg)

$-0.69 (-2.86%)
Prev Close
$24.12
Open
$23.70
Day's High
$23.70
Day's Low
$23.10
Volume
37,104
Avg. Vol
31,376
52-wk High
$27.87
52-wk Low
$20.18

Search Stocks

Summary

Name Age Since Current Position

Yasuchika Hasegawa

 66 2003 President, Representative Director

Deborah Dunsire

 50 2012 President of Subsidiary, Director

Frank Morich

 59 2011 Chief Commercial Officer, President of Subsidiary, Director

Tadataka Yamada

 67 2011 Chief Medical and Scientific Officer, Director

Yasuhiko Yamanaka

 57 2012 Managing Director

Toyoji Yoshida

 65 2011 Managing Director, President of Subsidiary

Masato Iwasaki

 54 2012 Chief Director of Pharmaceutical Sales, Director

Yorihiko Kojima

 71 2011 Independent Director

Fumio Sudo

 72 2011 Independent Director

Kenjiro Morimoto

 IR Contact Office
» Insider Trading

Biographies

Name Description

Yasuchika Hasegawa

 Mr. Yasuchika Hasegawa has been serving as President and Representative Director in Takeda Pharmaceutical Company Limited, since June 2003. He is also working for Japan Association of Corporate Executives. He joined the Company in April 1970. His previous titles include Chief Director of Pharmaceutical International Business, Director of Business Planning and Director of Business Strategy in the Company.

Deborah Dunsire

 Ms. Deborah L. Dunsire has been serving as Director in Takeda Pharmaceutical Company Limited, as well as President in a subsidiary Millennium Pharmaceuticals, Inc., since June 2012. She used to work for Sandoz Ltd. and Novartis Pharmaceuticals Corporation.

Frank Morich

 Mr. Frank Morich has been serving as Chief Commercial Officer and Director in Takeda Pharmaceutical Company Limited, as well as President of a subsidiary, since November 2011. He is also serving as Vice President of another subsidiary. He used to work for other companies including Innogenetics NV.

Tadataka Yamada

 Mr. Tadataka Yamada has been serving as Chief Medical and Scientific Officer and Director in Takeda Pharmaceutical Company Limited since November 2011. He is also serving as Vice President in a subsidiary, Director in Agilent Technologies, Inc. He used to work for other companies including GlaxoSmithKline plc.

Yasuhiko Yamanaka

 Mr. Yasuhiko Yamanaka has been serving as Managing Director in Takeda Pharmaceutical Company Limited, since April 2012. He joined the Company in April 1979, and previously served as Director of Business Strategy, Chief Director of Pharmaceutical Sales and Director in the Company.

Toyoji Yoshida

 Mr. Toyoji Yoshida has been serving as Managing Director in Takeda Pharmaceutical Company Limited, as well as President in a subsidiary, since June 2011. He joined the Company in July 1971. His previous titles include Manager of Public Relations in General Affairs and Human Resources Unit, Director of Corporate Communication and Director in the Company.

Masato Iwasaki

 Mr. Masato Iwasaki has been serving as Chief Director of Pharmaceutical Sales and Director in Takeda Pharmaceutical Company Limited since June 2012. He joined the Company in April 1985 and used to serve as Director of Product Strategy.

Yorihiko Kojima

 Mr. Yorihiko Kojima has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2011. He is also serving as Chairman of the Board of Mitsubishi Corporation, Independent Director of SONY CORPORATION and Mitsubishi Heavy Industries, Ltd., and working for Keidanren.

Fumio Sudo

 Mr. Fumio Sudo has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2011. He is also serving as Independent Director in JS Group Corporation, New Otani Co., Ltd. and Taisei Corporation, and also working for JFE Holdings, Inc. He used to serve as President and Representative Director in a company that is under the new name, JFE Steel Corporation, and worked for Japan Broadcasting Corporation.

Kenjiro Morimoto

Insider Trading

» Full list on Insider Trading
Search Stocks